The In Vitro Diagnostic Sector is estimated at USD 102.18 billion in 2024, and is expected to reach USD 131.66 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029). The outbreak of the COVID-19 pandemic has underscored the importance of IVD, fueling the demand for diagnostic kits and reagents for accurate and rapid disease detection. This surge in demand has positively impacted the market, highlighting the indispensable role of IVD in combating infectious diseases like COVID-19.